XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2024
Accounting Policies [Abstract] |
SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER SHARE | The following table summarizes the shares of common stock that were potentially issuable but were excluded from the computation of diluted net loss per share for the three months ended March 31, 2024 and 2023 as such shares would have had an anti-dilutive effect: SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER SHARE
|  | As of March 31, |
|  | 2024 |  |  | 2023 |
Stock options (a) |  |  | 90,833 |  |  |  | 146,191 |
Warrants (b) |  |  | 16,725 |  |  |  | 16,725 |
Unvested restricted stock |  |  | 193,217 |  |  |  | 181,887 |
Anti-dilutive securities |  |  | 193,217 |  |  |  | 181,887 |
| (a) | Shares underlying stock options assumed pursuant to the merger agreement with Precision Healing, Inc. (“Precision Healing”) in April 2022.
| (b) | Shares underlying warrants assumed pursuant to the merger agreement with Precision Healing in April 2022.
SCHEDULE OF REVENUE FROM PRODUCT SALES AND ROYALTIES | Revenue streams from product sales and royalties are summarized below for the three months ended March 31, 2024 and 2023. SCHEDULE OF REVENUE FROM PRODUCT SALES AND ROYALTIES
|  | Three Months Ended |
|  | March 31, |
|  | 2024 |  |  | 2023 |
Soft tissue repair products |  | $ | 16,082,292 |  |  | $ | 12,872,481 |
Bone fusion products |  |  | 2,454,346 |  |  |  | 2,599,186 |
Royalty revenue |  |  | - |  |  |  | 50,250 |
Total Net Revenue |  | $ | 18,536,638 |  |  | $ | 15,521,917 |
SCHEDULE OF PROPERTY AND EQUIPMENT | SCHEDULE OF PROPERTY AND EQUIPMENT
|  | Useful |  | March 31, |  |  | December 31, |
|  | Life |  | 2024 |  |  | 2023 |
Computers |  | 3-5 years |  | $ | 215,500 |  |  | $ | 194,788 |
Office equipment |  | 3-7 years |  |  | 214,190 |  |  |  | 201,785 |
Furniture and fixtures |  | 5-10 years |  |  | 304,338 |  |  |  | 304,338 |
Leasehold improvements |  | 2-5 years |  |  | 166,871 |  |  |  | 134,170 |
Internal use software |  | 5 years |  |  | 1,618,999 |  |  |  | 1,618,999 |
Property and equipment, gross |  |  |  |  | 2,519,898 |  |  |  | 2,454,080 |
Less accumulated depreciation |  |  |  |  | (1,329,093 | ) |  |  | (1,196,124 | )
Property and equipment, net |  |  |  | $ | 1,190,805 |  |  | $ | 1,257,956 |
SCHEDULE OF CHANGES IN FAIR VALUE FOR CONTINGENT EARNOUT CONSIDERATION | SCHEDULE OF CHANGES IN FAIR VALUE FOR CONTINGENT EARNOUT CONSIDERATION
Balance at December 31, 2023 |  | $ | 3,823,001 |
Changes in fair value of earnout liabilities |  |  | (65,678 | )
Balance at March 31, 2024 |  | $ | 3,757,323 |

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 360 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1 + Details
Name: | us-gaap_PropertyPlantAndEquipmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments. + References No definition available. + Details
Name: | us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration